Here is a link to the video of Dr Fred Kaplan's and Dr Eileen Shore's POHA Symposium presentation.
Thank you to all of our virtual attendees an speakers who shared in a day of learning from Dr. Fred Kaplan and Dr. Eileen Shore. It was so nice to see our POHA familes from 5 countries and 12 states. More details will be shared soon so please check back!
2021 Virtual Symposium
Please join us for a virtual sumposium on January 31, 2021 at 1:00 pm EST to 3:00pm. Here you will hear from the world's leading researchers Dr. Frederick Kaplan and Dr. Eileen Shore. There will also be breakout rooms for patients, parents and siblings. Keep checking your email and Facebook for updates and registration information.
2016 SYMPOSIUM AND WINE TASTING FUNDRAISER
2016 Symposium Families posing with Dr. Kaplan and Dr. Shore
We may need help with translations so that all families can have access to information they understand.
Eighty-five FOP families and nine POH families attended the Third International Symposium on FOP/POH, held November 2-5, 2000 in Philadelphia, PA.
The POHA relies on donations and fundraisings events to help us reach our goals of sponsoring research and educating people about POH.
Progressive Osseous Heteroplasia Association
1460 Bolingbrook Drive
517 Risley Road
Brigantine , NJ 08203
If you are not a member, we invite you to join the IFOPA. This organization represents FOP, the sister disease to POH. Research on both diseases is conducted in the same laboratory, directed by Dr. Eileen Shore and Dr. Fred Kaplan. You will receive "The FOP Connection a quarterly newsletter which provides research updates on both FOP and POH.
News, Articles and Papers
- Regeneron Announces Encouraging Garetosmab Phase 2 Results in Patients with Ultra-Rare Debilitating Bone Disease
- Paternally Inherited Inactivating Mutations of the GNAS1 Gene In Progressive Osseous Heteroplasia
- Perspective: Progressive Osseous Heteroplasia
- Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases
- Diagnostic and Mutational Spectrum of Progressive Osseous Heteroplasia (POH) and Other Forms of GNAS-Based Heterotopic Ossification
Regeneron Announces Encouraging Garetosmab Phase 2 Results in Patients with Ultra-Rare Debilitating Bone Disease
Paternally Inherited Inactivating Mutations of the GNAS1 Gene In Progressive Osseous Heteroplasia
EILEEN M. SHORE, PH.D., JAIMO AHN, PH.D., SUZANNE JAN DEBEUR, M.D., MING LI , B.A., MEIQI XU, B.S., R.J. MC KINLAY GARDNER, M.B., MICHAEL A. ZASLOFF, M.D., PH.D., MICHAEL P. WHYTE, M.D., MICHAEL A. LEVINE, M.D., AND FREDERICK S. KAPLAN, M.D.
N Engl J Med, Vol. 346, No. 2; January 10, 2002; www.nejm.org
Perspective: Progressive Osseous Heteroplasia
FREDERICK S. KAPLAN and EILEEN M. SHORE
Journal of Bone and Mineral Research; Volume 15, Number 11, 2000
Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases
FS Kaplan, R Craver, GD MacEwen, FH Gannon, G Finkel, G Hahn, J Tabas, RJ Gardner and MA Zasloff
J Bone Joint Surg Am. 1994;76:425-436.